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ABSTRACT
INTRODUCTION: Thin-layer chromatography (TLC) is a quick, inexpensive microscale technique appli-
cable for determination of the number of components in a mixture, monitoring the progress of an organic 
reaction, verification of substance identity and analysis of the fraction obtained from column chromatog-
raphy.
AIM: The aim of our work is to develop a rapid TLC method for related substance identification, purity elu-
cidation, and control of synthesis of metronidazole in dosage forms and during synthesis of derivatives.
MATERIALS AND METHODS: A rapid and reproducible TLC method for quality determination of met-
ronidazole derivatives is described. The samples and standard were separated on silica gel 60 with fluores-
cent indicator UV254 plates with three different mobile phases: A) acetic acid-ammonia-acetone-methylene 
chloride cyclohexane (1:2:3:3:1), B) toluene-chloroform-methanol (2:7:1), C) toluene-chloroform-ethanol-
acetic acid-ammonia (9:8:1:1:1). The visualization of spots was done at 254 nm.
RESULTS: As most appropriate was established to be the mobile phase consisting of toluene- chloroform-
ethanol-acetic acid-ammonia (9:8:1:1:1). The identification and determination of metronidazole in analyzed 
drug formulations were proved by the correspondence between the Rf of drug samples and reference stan-
dard Rf-0.58.
CONCLUSION: The TLC method for related substance determination of metronidazole in drug formula-
tions is an informative, rapid, and reproducible method. The method may be applied for further analysis 
and monitoring of synthesis of new metronidazole derivatives.
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INTRODUCTION
Metronidazole is an antimicrobial drug. Its 
spectrum of activity is determined by the possibil-
ity of susceptibility microorganisms to activate the 
drug. The metronidazole structure is illustrated on 
Fig. 1.
The chemical structure of nitroimidazole de-
rivatives, such as metronidazole, includes some ba-
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sic elements required for all of them. The imidazole 
heterocyclic ring constructs the main scaffold and 
the presence of a nitro group is essential for antimi-
crobial activity. However, they may be related to pro 
drugs, whose activation is based on reduction lead-
ing to formation of highly reactive products. The an-
tibacterial and antiprotozoal activities are propor-
tional to the concentration of the activated drug in 
the target cell. The mechanism of their activity in-
volves four main steps. In the first two steps the drug 
enters into the cells by passive diffusion and an elec-
tron is transferred to the nitro group of metronida-
zole. The result of this step is obtaining of short-lived 
nitroso free radical with cytotoxic activity and pos-
sibility of interaction with cellular DNA. The third 
step is based on binding of the obtained nitroso free 
radical to the microorganism DNA and the subse-
quent damage of the DNA. The last step is a release 
of final products (1).
Metronidazole is applicable to the treatment of 
severe anaerobic infectious such as intraabdominal 
operation or other surgical procedures with different 
localization. Therefore, there are various pharma-
ceutical preparations containing metronidazole such 
as tablets, vaginal globules, and topical creams (2).
A lot of different methods for purity elucidation 
and related substance identification of metronida-
zole derivatives are described. The literature survey 
includes different types of analytical techniques for 
quality and quantity determination of metronidazole 
in body fluids and various drug forms, for example, 
HPLC (3), GC (4), TLC chromatographic methods 
(5), ultraviolet spectroscopy (6) and voltammetry (7).
Thin-layer chromatography (TLC) is a rapid 
and routine analytical method suitable for monitor-
ing the progress of an organic reaction, determina-
tion of the number of components in a mixture, ver-
ification of substance’s identity, and analysis of the 
fraction obtained from column chromatography (8). 
TLC is a highly selective method and it has proven 
to be as sensitive as HPLC in many analytical pro-
cedures. Other advantages are low-cost analyses; a 
small quantity of the mobile phase is enough for de-
termination of a high number of samples, there is 
minimal sample preparation (9).
AIM
The aim of the present work is to develop а rap-
id TLC method for quality determination of metro-
nidazole dosage forms, their purity elucidation and 
further application of this method for control of the 
synthesis of new metronidazole derivatives.
MATERIALS AND METHODS
Metronidazole standard (Fluorochem, 
Lot:FCC26022), toluene (anhydrous, 99.8%, Sigma-
Aldrich), chloroform (HPLC grade, ≥99.9%, Sigma-
Aldrich), methanol (HPLC, ≥99.9%, Sigma-Aldrich), 
acetic acid (glacial, Reagent Plus®, ≥99%, Sigma-Al-
drich), ammonia puriss. (anhydrous, ≥99.95%, Sig-
ma-Aldrich), acetone (HPLC, ≥99.9%, Sigma-Al-
drich), dichloromethane (Sigma-Aldrich), cyclo-
hexane (anhydrous, 99.5%, Sigma-Aldrich), ethanol 
(ethanol, ≥99.5%, for HPLC, Sigma-Aldrich) were 
used. Two different tablet dosage forms of metro-
nidazole were kindly donated by the MedUniPhar-
ma pharmacy and were claimed to contain 500 mg 
metronidazole. The following equipment was used: 
sample applicator- 50 µL micro syringe (Hamilton, 
Bonaduz, Switzerland), TLC chamber (outer dimen-
sions: 22 cm x 12 cm x 22 cm, CAMAG), pre-coated 
TLC sheets ALUGRAM® SIL G/UV254 (0.20 mm, sil-
ica gel 60 with fluorescent indicator UV254, outer di-
mensions: 10 x 20 cm, MACHERY-NAGEL GmbH 
& Co. KG, Germany), Kern analytical balance, ABS 
220-4N, AC/DC input 220 V AC, UK plug
EXPERIMENTAL PROCESS
A rapid and reproducible TLC determination of 
metronidazole drug forms is described. Based on lit-
erature data, we used three different mobile phases 
to determine the most sensitive and express among 
them for qualitative determination of metronidazole 
dosage form-tablets. 
Fig. 1. Chemical structure of metronidazole
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Sample Preparation
Standard solution of 50 mg metronidazole was 
dissolved in methanol and diluted with the same sol-
vent to 10 mL.
Solutions from two different tablet dosage 
forms containing metronidazole were tested. To 
sample powder tablets equivalent to 50 mg metro-
nidazole, we added 5 mL of methanol, diluted with 
methanol to 10 mL, and mixed to complete dilution.
The standard solution of metronidazole and the 
solutions of two tablet dosage formulations of metro-
nidazole were freshly prepared on the day of analysis.
Mobile Phase
a. acetic acid-ammonia-acetone-methylene 
chloride-cyclohexane (1:2:3:3:1)




Chromatographic analysis was achieved by us-
ing three different pre-coated silica gel plates SIL G/
UV254. Five µL from each solution were spotted onto 
SIL G/UV254plates, keeping 20 mm distance between 
spots. The plates were developed at room tempera-
ture in glass chromatographic chambers, previous-
ly pre-saturated for 90 minutes with mobile phases: 
A) acetic acid-ammonia-acetone-methylene chloride 
cyclohexane (1:2:3:3:1), B) toluene-chloroform-meth-
anol (2:7:1), and C) toluene- chloroform-ethanol-ace-
tic acid-ammonia (9:8:1:1:1). The solvents allowed to 
the formation of a path of 12 cm from the start line. 
Detection
Plates were air dried and examined under 
screened ultraviolet light at 254 nm. The standards 
and samples appeared as violet spots. Relative Rf val-
ues were determined for each plates in each solvent 
system (A, B, C).
RESULTS AND DISCUSSION
The present study evaluates three different sol-
vent systems as mobile phases for the most rapid and 
effective TLC determination of metronidazole dos-
age forms.
In the three obtained chromatograms are de-
tected spots of standard substance and samples cor-
responding in size and color. We had tested various 
mobile phases in order to identify the optimal sys-
tem for determination of metronidazole dosage for-










Detection in UV 





0.72 0.72 0.72 violet
toluene-chloroform-methanol 
(2:7:1) 0.63 0.63 0.63 violet
toluene-chloroform-ethanol-
acetic acid-ammonia (9:8:1:1:1) 0.58 0.58 0.58 violet
Table 1. Chromatographic characteristics of metronidazole
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mulation by TLC (Fig. 2). To evaluate the precision of 
the experiment and repeatability, we did three repli-
cate analyses per day for five consecutive days. The 
Rf values in the examined mobile phases are present-
ed in Table 1.
We found the applied mobile phases to be sen-
sitive enough for identification and determination 
of metronidazole-containing compounds. The most 
optimal Rf values were observed using the mobile 
phase: toluene- chloroform-ethanol-acetic acid-am-
monia (9:8:1:1:1). The spots were clearly visible and 
similar, too. The identification and determination of 
metronidazole in analyzed drug formulations was 
proven by the correspondence between the Rf of the 
drug samples and reference standard Rf, both equal 
to 0.58. In a previous study we established that the 
excipients are part of tablet dosage forms and do not 
affect the sensitivity and specificity of metronidazole 
detection.
CONCLUSION
In conclusion, a fast, selective and reproducible 
TLC method for purity elucidation and related sub-
stance identification was developed. We found that 
all of the used mobile phases are sensitive enough for 
identification and determination of metronidazole 
containing compounds. The most optimal Rf values 
were observed using a mobile phase: toluene-chlo-
roform-ethanol-acetic acid-ammonia (9:8:1:1:1). The 
method may be applied for further analysis of newly 
obtained metronidazole derivatives and for monitor-
ing of the synthesis of new metronidazole derivatives.
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